Glutaryl-CoA dehydrogenase modulates ferroptosis-associated phenotypes in lung cancer cells in association with histone crotonylation and NEAT1
Аннотация
Resistance to ferroptosis has been linked to metabolic reprogramming in lung cancer, but the epigenetic control of this process remains unclear. We established an integrated experimental workflow combining gene perturbation, metabolite quantification, ferroptosis-associated phenotyping, histone-crotonylation analysis, promoter-level assays, and The Cancer Genome Atlas (TCGA)-based bioinformatics to characterize relationships among glutaryl-CoA dehydrogenase ( GCDH ), nuclear paraspeckle assembly transcript 1 ( NEAT1 ), and ferroptosis-associated readouts in A549 and H1299 cells. GCDH knockdown reduced day-4 Cell Counting Kit-8 (CCK-8) absorbance from 1.30 to 0.62 in A549 cells and from 1.40 to 0.72 in H1299 cells, while increasing malondialdehyde (MDA) from 5 to 18 and 4 to 12 nmol/mL, respectively. Fe²⁺ levels increased from 1.6 to 4.8 nmol/L and from 1.0 to 5.4 nmol/L, accompanied by decreased GPX4 and SLC7A11. GCDH depletion also reduced histone H3 lysine 27 crotonylation (H3K27cr)/total H3 from 1.00 to 0.42 and 0.39, and lowered total NEAT1 expression to 0.25 and 0.13, respectively. GCDH overexpression partially attenuated glutamine-metabolism-associated and ferroptosis-associated changes induced by C968 or NEAT1 silencing. These results support a GCDH -associated regulatory model linking H3K27 crotonylation, total NEAT1 expression, steady-state glutamine-related metabolites, and ferroptosis-associated stress, without establishing H3K27cr as independently causal or ferroptosis as definitively induced.